MAPT and Alzheimer disease: Likewise, the concentration of tau protein andamyloid β (Aβ) in the cerebral-spinal fluid (CSF) appears to havesome diagnostic value in probable AD, but it is an invasiveprocedure and its value for predicting AD has received onlylittle attention thus far [15].